Title: Cardiac Autonomic Neuropathy
1Cardiac Autonomic Neuropathy
Dr. Ravishankar. S.B Dept. of Medicine J.S.S.
Hospital
2Autonomic Innervation of Cardia
3Definition
Presence of at least two abnormal out of
four performed autonomic functions
- Deep breathing
- Lying to Standing
- Valsalva Manoeure
- Orthostatic hypotension
- Drop in ppSBP
4How frequent is it ?
Prevalence
8 - 90 Different patient cohorts ( Type
1/2 Clinic / Population ) Different
assessment modalities Different minimal
Criteria used in definition Duration of
Diabetes
Type 2 ? 25 - 40
5How does it manifest?
Major Syndromes
Cardiac denervation Exercise intolerence Orthostat
ic hypotension
- Reduced heart rate variability (HRV) is the
earliest - indicator of CAN
6Why should we know about CAN?
Mortality 27 / 10 year
- Silent Cardiac Ischemia
- Arrhythmia's
- Sudden Cardiac Death
- Increased LV Hypertrophy
- Altered Coronary Vasomotor Dynamics
- Platelet Stickiness
7How can we diagnose or assess CAN?
Non-Invasive Bedside Tests
Blood Pressure response to standing ECG - QT
prolongation RR - Variation during deep
breathing Valsalva maneuver
8How can we diagnose or assess CAN?
Assessment of Sympatho-Vagal Activity
Power Spectral Analysis of HRV
Assessment of Myocardial Sympathetic innervation
MIBG Imaging
Association with Microalbuminuria
9Response to standing
Autonomic Reflex Arc
- Blood Pressure REST 1min 5min
- Fall in BP ?
30/15 -
- Heart Rate Record ECG
- 30 s 15 s ( RR ) lt
1.4 -
10RR - Variation during deep breathing
Parasympathetic Influence on heart
- Respiratory rate of 5/min
- Take continuous ECG for 1 min
-
- Maximum- Minimum heart rate ? 15 beats /min
- Ratio of longest RR interval ( Expiration )
Shortest - RR interval ( Inspiration ) EI 1.2
11Valsalva maneuver
Autonomic Reflex Arc
- Blow into the pipe of BP tubing to maintain 40
mm of - Hg for 15 sec.
- Phase I Rise in BP
- Phase II ? in BP Tachycardia.
- Phase III Fall in BP
- Phase IV Overshoot of BP Bradycardia.
12Valsalva maneuver
Valsalva Ratio Longest RR Shortest RR ?
1.4
ppSBP
Mean value of SBP during 2 hours after each
meal intake. 21 - 30 mm of Hg.
Corrected QT
Prolonged
13Variables Influencing CAN testing
- Time of the day
- Metabolic Status
- Distance from Insulin Meal
- Coffee Smoking Avoidance
- Presence of Cardiovascular disease drugs
- Posture - Standing sitting reduces HRV
14How does it matter to the patient? - Clinical
Implications
- Exercise prescription
- Tread mill testing
- Induction of Anaesthesia
- Avoid - Straining at Stool urine
- - Hot Showers
- - Hot weather
-
15Can we treat CAN or retard its progression ?
- Strict Glycemic Control
-
- Intensive therapy retards development of
abnormal RR - variation and slows the
deterioration of Autonomic dysfunction - DCCT Trialists
- Reversible metabolic Component of CAN
- Buerger et al.
- Am J Cardiol 1999 Sep 15 84 (6)
16Alpha - lipoic acid
800 mg /day for 4 months
Reversion of baseline HRV as documented by
spectral analysis Root mean Square successive
difference in RR in Type 2 DM.
Diabets Care 1999, 20,3,369
17Quinapril
20 mg/day 3 Months
- Mainly normalizes parasympathetic variables .
- Effects are attributed to incresed vagal tone
through - baroreceptor activity
- Quinapril seems to combine ?-blokade and ACE
inhibition. - This effect is not seen with Lisinopril
Diabetes Care vol 20, 3, Mar 1997
18Message to take home
- CAN is common in Type 2 DM
- Diagnosis can be made at bedside with simple
tests - Advise the patients about the precautions to take
- Control DM intensely in those with CAN
19Message to take home
- Be on the alert for non specific symptoms
- Think of CAN when doing Tread Mill
- Think of CAN on Pre- Op/ Anaesthetic assessment
- Try medication ?